NEW YORK, June 2, 2023 /PRNewswire/ — Jakubowitz Law announces that an investigation into potential securities fraud allegations has commenced on behalf of shareholders of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) To be contacted by a member of our team, fill out the form: https://claimyourloss.com/securities/reata-class-action-loss-submission-form/?id=40181&from=4 Further details on the investigation: On…Read More
RETA FRAUD ALERT Jakubowitz Law is Investigating Reata Pharmaceuticals Inc in Connection with Potential Violations of Federal Securities Laws MarketScreener
